StockComparison Logo
vs

CE vs BIO-B

Comparison between Celanese Corp - Series A (CE, Company) and Bio-Rad Laboratories Inc - Class B (BIO-B, Company).

CE is from the Basic Materials sector, while BIO-B is from the Healthcare sector.

5-Year PerformanceBIO-B has outperformed CE, delivering a return of -14.7% compared to -18.4%

CE vs BIO-B - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
CE
$6.57B
Winner
BIO-B
$6.60B
Max Drawdown
CE
84.96%
Winner
BIO-B
72.48%
Sharpe Ratio
Winner
CE
0.36
BIO-B
0.18
5Y Beta
CE
1.31
Winner
BIO-B
-0.11
Industry
CE
Chemicals
BIO-B
Medical Devices
P/E Ratio
CE
-5.77
Winner
BIO-B
-13.39
Forward P/E
Winner
CE
10.30
BIO-B
28.90
PEG Ratio
CE
4.42
Winner
BIO-B
1.21
Dividend Yield
CE
0.21%
BIO-B
N/A
5Y Dividends CAGR
CE
-43.48%
BIO-B
N/A
Debt to Equity
CE
352.94%
Winner
BIO-B
11.72%
Free Cash Flow Yield
Winner
CE
13.36%
BIO-B
5.41%
P/S Ratio
Winner
CE
0.69
BIO-B
2.58
P/B Ratio
CE
1.54
Winner
BIO-B
1.00

CE vs BIO-B - Historical Returns

Returns include dividend reinvestment.

1M
CE
-10.10%
Winner
BIO-B
-3.45%
3M
CE
+1.71%
Winner
BIO-B
+2.14%
6M
Winner
CE
+53.46%
BIO-B
-13.93%
1Y
CE
+6.47%
Winner
BIO-B
+6.94%
5Y(CAGR)
CE
-18.44%
Winner
BIO-B
-14.66%
10Y(CAGR)
CE
-0.46%
Winner
BIO-B
+6.54%
Max(CAGR)
CE
+7.47%
Winner
BIO-B
+12.54%

CE vs BIO-B - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearCEBIO-B
2026+32.35%-13.93%
2025-38.05%-4.58%
2024-54.38%+1.54%
2023+55.63%-20.76%
2022-37.55%-44.94%
2021+35.90%+25.91%
2020+9.77%+54.89%
2019+37.93%+60.70%
2018-14.05%-3.46%
2017+37.19%+30.08%
2016+21.58%+33.03%
2015+14.23%+14.67%
2014+10.81%-2.37%
2013+20.17%+15.80%
2012-2.50%+6.31%
2011+5.23%-9.98%
2010+24.49%+6.86%
2009+147.37%+31.80%
2008-70.95%-30.83%
2007+68.02%+28.86%
2006+32.00%+28.31%
2005+20.04%+14.04%
2004N/A-2.64%
2003N/A+36.47%
2002N/A+32.81%
2001N/A+103.17%
2000N/A+36.25%
1999N/A-0.56%

CE vs BIO-B Drawdown Comparison

The maximum drawdown for CE was -84.87%, occurring on Mar 3, 2009. Recovery took 716 trading sessions.

The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The current CE drawdown is -66.96%. The current BIO-B drawdown is -67.33%.

RankCEBIO-B
#1-84.87%
Jun 23, 2008 - Apr 26, 2011
-72.48%
Sep 10, 2021 - Apr 9, 2025
#2-78.96%
Mar 28, 2024 - Nov 20, 2025
-50.14%
Aug 11, 2008 - Apr 20, 2010
#3-53.33%
Nov 26, 2019 - Nov 9, 2020
-35.34%
Mar 1, 2000 - Nov 29, 2000
#4-48.67%
Jan 5, 2022 - Mar 20, 2024
-34.33%
Jun 19, 2002 - May 20, 2003
#5-45.39%
Jul 21, 2011 - Oct 21, 2013
-31.86%
Sep 4, 2018 - Aug 2, 2019
#6-28.13%
Jul 31, 2018 - Sep 5, 2019
-31.00%
May 3, 2011 - Jan 9, 2014
#7-25.76%
Jul 2, 2015 - Oct 27, 2016
-27.68%
Nov 8, 2007 - Aug 11, 2008
#8-23.96%
May 8, 2006 - Dec 5, 2006
-25.78%
May 3, 2010 - Mar 7, 2011
#9-23.70%
Dec 14, 2007 - Apr 21, 2008
-23.33%
Dec 26, 2003 - Aug 2, 2005
#10-22.89%
Jul 13, 2007 - Oct 29, 2007
-22.65%
Feb 1, 2007 - Sep 27, 2007
#11-22.59%
Jul 3, 2014 - Apr 17, 2015
-20.71%
May 17, 2002 - Jun 17, 2002
#12-22.32%
Apr 1, 2005 - Jul 20, 2005
-19.75%
Feb 18, 2020 - Apr 14, 2020
#13-18.75%
Aug 23, 2005 - Jan 17, 2006
-19.59%
Jun 6, 2003 - Dec 26, 2003
#14-15.96%
Nov 14, 2013 - Apr 21, 2014
-18.74%
Feb 20, 2014 - Mar 12, 2015
#15-15.41%
Nov 6, 2007 - Dec 12, 2007
-18.70%
Nov 6, 2020 - Feb 12, 2021

Correlation

Correlation between CE and BIO-B is 0.87 which considered as a strong positive correlation - the stocks tend to move together.

0.87
-101

Select Stocks to Compare